Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Deciphera Pharmaceuticals (NASDAQ:DCPH) stock moved upwards by 72.2% to $25.22 during Monday’s regular session. The market value…
SELLAS Announces Publication Of Preclinical Data On Its Highly Selective CDK9 Inhibitor, SLS009, In Oncotarget
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today
SELLAS Life Sciences To Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients At The 2024 European School Of Haematology Conference
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today
Zijin Mining Invests $97M In Solaris Resources, Deal To Bolster Copper Project In Ecuador
China-based Zijin Mining is investing $97 million in Solaris Resources. Proceeds will go toward an Ecuador-based project.
SELLAS Life Sciences Receives FDA Fast Track Designation For SLS009 For Treatment Of Relapsed/Refractory Acute Myeloid Leukemia And Provides Updated Data For Phase 2a Study Of SLS009 In Relapsed/Refractory Acute Myeloid Leukemia Patients
- Phase 2a Enrollment Completed in 45 mg Safety Cohort: Median Overall Survival (OS) Not Reached; 89% of Patients Alive with Significant Antileukemic Effect Observed in 87.5% of Evaluable Patients -- First Enrolled
Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday.
The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P 500 also rose, gaining, 0.09% to 4,708.93.
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Why Sellas Life Sciences Shares Are Nosediving
Sellas Life Sciences Group Inc (NASDAQ: SLS) shares are trading lower by 35.7% to $0.58 Thursday afternoon.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Omega Therapeutics (NASDAQ:OMGA) shares increased by 99.6% to $5.45 during Thursday’s regular session. The market value of…